• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    ---
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAAXT
Aamaxan Transport Group Inc
20.0
0.0x
---
United StatesQTNTQ
Quotient Ltd
303.7K
0.0x
---
United StatesLNSR
LENSAR Inc
29.1M
-1.2x
---
United StatesBIOL
BIOLASE Inc
20.0M
-0.2x
---
United StatesAHPI
Allied Healthcare Products Inc
4.5M
-0.5x
---
United StatesTTOO
T2 Biosystems Inc
12.0M
-0.1x
---
As of 2023-01-26

Company Information

Aamaxan Transport Group, Inc. is a shell company as it has no or nominal operations. Aamaxan was dormant from mid-2000 until recently. The Company has been seeking, and will continue to seek, potential operating businesses and business opportunities with the intent to acquire or merge with such businesses. It is considered a development stage company and its principal purpose is to locate and consummate a merger or acquisition with a private entity. Effective April 15, 2008, the Company has completed the acquisition of Asian Business Management Group Limited (ABM). ABM, through its direct and indirect subsidiaries, including Shanghai Medical Technology Co., Ltd. (Shanghai Medical), a PRC company, is the provider of Hemodialysis equipment (HDE) and other related supplies and services, including disposable and diagnostic products and pharmaceuticals, throughout Eastern China.

Contact Information

Headquarters
Suite 6B 1440 Hongqiao Road, Changning DistrictSHANGHAI, SHA, China 200336
Phone
215-080-5789
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Zhong Chen
Acting Chief Financial Officer
Yifei Xu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$20.00
Revenue (TTM)
$39.1M
Shares Outstanding
16.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$44.02
Book Value
$94.03
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
0.0x
Operating Margin
27.48%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.